| 6204- | Cuc, | Preliminary investigation of the anti-colon cancer activity of cucurbitacin C from cucumber: A network pharmacological study and experimental validation |
| - | in-vitro, | Colon, | HCT116 |
| 6205- | CUR, | Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis |
| - | Review, | Var, | NA |
| 5783- | CUR, | EGCG, | The effects of tetrahydrocurcumin and green tea polyphenol on the survival of male C57BL/6 mice |
| - | in-vivo, | Nor, | NA |
| 5229- | CUR, | Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) |
| - | in-vitro, | Melanoma, | NA |
| 6050- | CUR, | SeNPs, | Efficacy of curcumin-selenium nanoemulsion in alleviating oxidative damage induced by aluminum chloride in a rat model of Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| 5397- | CUR, | SFN, | RES, | EGCG, | Ash | Targeting Cancer Stem Cells with Phytochemicals: Molecular Mechanisms and Therapeutic Potential |
| - | Review, | Var, | NA |
| 6421- | CUR, | Curcumin simultaneously improves mitochondrial dynamics and myocardial cell bioenergy after sepsis via the SIRT1-DRP1/PGC-1α pathway |
| - | in-vivo, | Nor, | NA |
| 6416- | CUR, | QC, | FA, | RES, | EGCG | Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders |
| - | Review, | AD, | NA |
| 6409- | CUR, | Curcumin prevents cisplatin-induced renal alterations in mitochondrial bioenergetics and dynamic |
| - | in-vivo, | Nor, | NA |
| 6408- | CUR, | Protective Effects of a Natural Product, Curcumin, against Amyloid β Induced Mitochondrial and Synaptic Toxicities in Alzheimer'S Disease |
| - | in-vitro, | AD, | SH-SY5Y |
| 6206- | CUR, | Bioavailability of Oral Curcumin in Systematic Reviews: A Methodological Study |
| - | Review, | Nor, | NA |
| 6207- | CUR, | Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6227- | CUR, | Revisiting Curcumin in Cancer Therapy: Recent Insights into Molecular Mechanisms, Nanoformulations, and Synergistic Combinations |
| - | Review, | Var, | NA |
| 6211- | CUR, | The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer |
| - | Review, | Var, | NA |
| 6213- | CUR, | Potentiality of Curcumin Against Radio-Chemotherapy Induced Oral Mucositis: A Review |
| - | Review, | Var, | NA |
| 6214- | CUR, | Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve |
| 6215- | CUR, | Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer |
| - | Review, | Var, | NA |
| 6216- | CUR, | Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials |
| - | Review, | Var, | NA |
| 6232- | CUR, | Rad, | Chemo, | The Effectiveness of Curcumin in Treating Oral Mucositis Related to Radiation and Chemotherapy: A Systematic Review |
| - | Review, | Var, | NA |
| 6231- | CUR, | Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling |
| - | in-vitro, | Liver, | HepG2 |
| 6230- | CUR, | Dual redox effects of 2,6-bis-(4-hydroxyl-3-methoxybenzylidene) cyclohexanone (BHMC) on human liver cancer cells, HepG2 via ROS, glutathione and Nrf2/Keap1 pathway |
| - | in-vitro, | Liver, | HepG2 |
| 6229- | CUR, | Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells |
| - | in-vitro, | Cerv, | NA |
| 6228- | CUR, | A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability |
| - | Study, | Nor, | NA |
| 6212- | CUR, | Rad, | Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers |
| - | Review, | Var, | NA |
| 6226- | CUR, | Rad, | Analysis of Curcumin as a Radiosensitizer in Cancer Therapy with Serum Survivin Examination: Randomised Control Trial |
| - | Trial, | Cerv, | NA |
| 6225- | CUR, | Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance |
| - | Review, | Var, | NA |
| 6224- | CUR, | Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer |
| - | Review, | Var, | NA |
| 6223- | CUR, | Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects |
| - | Review, | Var, | NA |
| 6222- | CUR, | Anticancer Molecular Mechanisms of Curcuminoids: An Updated Review of Clinical Trials |
| - | Review, | Var, | NA |
| 6221- | CUR, | Oxidative Stress and Cancer: Harnessing the Therapeutic Potential of Curcumin and Analogues Against Cancer |
| - | Review, | Var, | NA |
| 6219- | CUR, | Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action |
| - | Review, | Var, | NA |
| 6218- | CUR, | Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications |
| - | Review, | Var, | NA |
| 6217- | CUR, | Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway |
| - | Review, | Var, | NA |
| 6209- | CUR, | Curcumin as a complementary treatment in oncological therapy: a systematic review |
| 6208- | CUR, | Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial |
| - | Trial, | Nor, | NA |
| 6210- | CUR, | Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis |
| 6720- | CUR, | SFN, | DHCA, | Synergistic Combinations of Curcumin, Sulforaphane, and Dihydrocaffeic Acid against Human Colon Cancer Cells |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | Nor, | FHC |
| 6770- | CUR, | A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin |
| - | Review, | Nor, | NA |
| 2312- | CUR, | Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy |
| - | Review, | Var, | NA |
| 2304- | CUR, | Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition |
| - | in-vitro, | Lung, | H1299 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Nor, | HEK293 |
| 2305- | CUR, | Mitochondrial targeting nano-curcumin for attenuation on PKM2 and FASN |
| - | in-vitro, | BC, | MCF7 |
| 2307- | CUR, | Cell-Type Specific Metabolic Response of Cancer Cells to Curcumin |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | Laryn, | FaDu |
| 2308- | CUR, | Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells |
| - | in-vitro, | Liver, | HepG2 |
| 2466- | CUR, | Regulatory Effects of Curcumin on Platelets: An Update and Future Directions |
| - | Review, | Nor, | NA |
| 2579- | CUR, | ART/DHA, | Curcumin-Artemisinin Combination Therapy for Malaria |
| - | in-vivo, | NA, | NA |
| 2654- | CUR, | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
| - | Review, | Var, | NA |
| 2688- | CUR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 2819- | CUR, | Chemo, | Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury |
| - | Review, | Var, | NA |
| 2820- | CUR, | Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways |
| - | in-vitro, | HCC, | HepG2 |
| 2821- | CUR, | Antioxidant curcumin induces oxidative stress to kill tumor cells (Review) |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid